Fig. 9From: Aptamer-labeled PLGA nanoparticles for targeting cancer cellsPhase contrast images of (a) Control GI-1 cells (b) GI-1 cells treated with Plain PLGA NPs (c) GI-1 cells treated with Plain PTX (d) GI-1 cells treated with PTX-PLGA NPs (e) GI-1 cells treated with Apt AS1411-PTX-PLGA NPs (f) GI-1 cells treated with non-specific aptamer-PTX-PLGA NPsBack to article page